Pseudomonas aeruginosa in skin infections of diabetic patients
DOI:
https://doi.org/10.62305/biosana.v6i4.1173Keywords:
Type 2 diabetes mellitus; diabetic foot; Pseudomonas aeruginosa; antimicrobial sensitivity; Bacterial resistanceAbstract
Diabetes mellitus is a metabolic disease that affects multiple organs, including the skin, predisposing patients to develop skin lesions that, due to their difficulty in healing, can become foci of infection. Colonization by microorganisms such as gram-positive bacteria and gram-negative bacteria such as Pseudomonas aeruginosa increases the risk of serious complications, including gangrene, osteomyelitis, and sepsis. Early identification of pathogens in these lesions is essential to improve clinical management and prevent complications in the diabetic population. 25 patients were analyzed, where a sample of the purulent skin lesion was taken in diabetic patients. A microbiological culture was then performed for the identification and isolation of Pseudomonas aeruginosa. Finally, an antibiogram was carried out to determine the levels of susceptibility and/or resistance to different antibiotics. The results showed that Pseudomonas aeruginosa was the most frequently isolated microorganism (48%). It was followed by (Staphylococcus aureus) (24%), Escherichia coli (20%), and (Klebsiella pneumoniae) (8%). In the antibiogram of Pseudomona aeruginosa, greater sensitivity was observed against third-generation cephalosporins and meropenem (83.3%), while the highest resistance corresponded to imipenem (33.3%).
Downloads
References
M.Cs. Joyce Yvette Ojeda Méndez, Boletín Epidemiológico, Diabetes Mellitus Primer Trimestre-2014, México, Subsecretaria de Prevención y Promoción de la salud, [Internet], 2014, disponible en: http://inger.gob.mx/pluginfile.php/1957/mod_resource/content/5/RepositorioCursos/Archivos/Cardiogeriatria/Tema_9/Cardio_Lectura_Boletin_Diabetes _Mellitus_tipo_2.pdf
Kurup R, Ansari AA. A study to identify bacteriological profile and other risk factors among diabetic and non-diabetic foot ulcer patients in a Guyanese hospital setting. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 1 de mayo de 2019;13(3):1871-6. doi:10.1016/j.dsx.2019.04.024
Mora Verdugo MA, Almeida Mendieta AJ, Espinoza Muñoz MS. Prevalencia de manifestaciones cutáneas y características clínico-demográficas de pacientes mayores de 30 años con Diabetes Mellitus tipo 2 de los centros de salud “Parque Iberia” y “Carlos Elizalde” del cantón Cuenca 2019. Universidad del Azuay. 2020.
Darwitz BP, Genito CJ, Thurlow LR. Triple threat: how diabetes results in worsened bacterial infections. Infection and Immunity. 2024; 92(9).
Das L, Smriti S, Dash RK, Singh N, Panda SS, Mohapatra I, et al. Clinico Microbiological Profile of Diabetic Foot Ulcers: A Retrospective Study. Cureus. 24 de octubre de 2025;17. doi:10.7759/cureus.95291
Yefou MD, Jingi AM, Etoga MCE, Mekobe FM, Agoons BB, Ngassam E, et al. Bacterial profile of diabetic foot infections and antibiotic susceptibility in a specialized diabetes centre in Cameroon. Pan Afr Med J. 2022;42:52. doi:10.11604/pamj.2022.42.52.31042 PubMed PMID: 35949468; PubMed Central PMCID: PMC9307920.
Kurup R, Ansari AA. A study to identify bacteriological profile and other risk factors among diabetic and non-diabetic foot ulcer patients in a Guyanese hospital setting. Diabetes Metab Syndr. 2019;13(3):1871-6. doi:10.1016/j.dsx.2019.04.024 PubMed PMID: 31235108.
Viswanathan V, Pendsey S, Radhakrishnan C, Rege TD, Ahdal J, Jain R. Methicillin-Resistant Staphylococcus aureus in Diabetic Foot Infection in India: A Growing Menace. Int J Low Extrem Wounds. septiembre de 2019;18(3):236-46. doi:10.1177/1534734619853668 PubMed PMID: 31256689.
Das L, Smriti S, Dash RK, Singh N, Panda SS, Mohapatra I, et al. Clinico Microbiological Profile of Diabetic Foot Ulcers: A Retrospective Study. Cureus. octubre de 2025;17(10):e95291. doi:10.7759/cureus.95291 PubMed PMID: 41287659; PubMed Central PMCID: PMC12640533.
Atlaw A, Kebede HB, Abdela AA, Woldeamanuel Y. Bacterial isolates from diabetic foot ulcers and their antimicrobial resistance profile from selected hospitals in Addis Ababa, Ethiopia. Frontiers in Endocrinology. 2022;13:987487.
Srivastava P, Sivashanmugam K. Eficacia de meropenem y ciprofloxacino a niveles subinhibitorios de la concentración mínima inhibitoria (CMI) frente a cepas de Pseudomonas aeruginosa extensamente resistentes a los fármacos (XDR) aisladas de pacientes con úlceras del pie diabético. Infection, Genetics and Evolution. 1 de agosto de 2021;92:104824. doi:10.1016/j.meegid.2021.104824
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 BIOSANA Health Scientific Journal. ISSN 2960-8481

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.




